Загрузка...
NKT cell adjuvants in therapeutic vaccines against hematological cancers
Immune adjuvants aimed at initiating or re-activating host immunity against poorly immunogenic cancers represent a potential tool for immunotherapy. By employing the natural killer T (NKT) cell agonist α-galactosylceramide in a whole tumor cell therapeutic vaccine approach, we have achieved potent s...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Landes Bioscience
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3583928/ https://ncbi.nlm.nih.gov/pubmed/23482240 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.22615 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|